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Abstract 
Background: Pregabalin is a novel drug used as an adjunct to multimodal 
analgesia for reducing post-operative pain. We aimed to compare the efficacy 
and side effects of two different pre-emptive doses of pregabalin (75 mg vs. 
150 mg) for attenuation of postoperative pain following laparoscopic 
cholecystectomy.  
Materials and Methods: This was a prospective randomized study where 70 
patients planned for elective laparoscopic cholecystectomy (LC) were enrolled 
and received a pre-emptive dose of oral pregabalin. Group A received 75 mg 
and Group B received 150 mg of Pregabalin (PGB) 1 hour before surgery. 
Assessment of static and dynamic pain was done at 0, 0-4, 4-8, 8-12, 12-16, 
16-24 hours post-surgery using Visual Analog Scale (VAS) Score. Adverse 
effects like postoperative nausea and vomiting (0-6 hr), headache, sedation, and 
respiratory depression (0-24 hr) were assessed at regular intervals.  
Results: There was no significant difference in static and dynamic pain 
perception at different timed intervals between the two groups. Even the total 
analgesic requirement in both groups was comparable. The incidence of 
Postoperative Nausea Vomiting (PONV) (p-value 0.04 ) and headache (P-
value 0.034) were statistically significant in Group B when compared to 
Group A.  
Conclusion: Preemptive PGB (75 mg) had a lesser incidence of PONV and 
headache. Therefore, from our results, we can conclude that a lower dose of 
PGB has lesser adverse effects, although the analgesic effects are comparable.  
Keywords: Pregabalin, Laparoscopic cholecystectomy, Pre-emptive dose, Post-
operative pain 
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Introduction 
Great progress was made in the direction of 
understanding the pathology and pharmacology of 
acute pain along with the improvement of surgical 
techniques. Pregabalin was initially approved for 
chronic neuropathic pain and partial seizure, but in the 
year 2001 beneficial effect of pregabalin for acute pain 
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was first published (1). Acute postoperative pain is still 
inadequately treated in nearly 20% of all surgical 
patients within the first 24 hours (2).  
A multimodal approach can provide significant 
benefits including reductions in pain intensity, opioid 
requirements, and opioid-related adverse events (3). 
With the invention of laparoscopic surgeries, the 
Patients often experience lesser pain and scarring, a 
speedy recovery with LC when compared to traditional 
open surgery. Pre-emptive analgesia is initiated before 
surgery to prevent the establishment of central 
sensitization evoked by the traumatic and 
inflammatory injuries occurring during surgery and in 
the early postoperative period (4). 
Pain in LC is a conglomeration of somatic pain 
caused by incision, deep intra-abdominal visceral pain, 
and referred shoulder pain (5). The postoperative 
neuropathic pain generated is probably due to the 
elevated temperatures of electrical scalpels and 
intraoperative nervous fiber dissection (6). Therefore, 
nociceptive, inflammatory, and neuropathic 
mechanisms mediate the perception of postoperative 
pain. The mechanisms of pain vary between 
individuals and different operative procedures (7). 
Various analgesic regimens and techniques are 
employed in multimodal opioid-sparing analgesia 
which targets multiple central and peripheral pain 
pathways. They act synergistically to enhance the 
analgesic requirement and minimize the dose of any 
single analgesic agent (8). 
Unlike other laparoscopic procedures, pain in 
LC is quite complex requiring multimodal analgesia. 
As a part of a multimodal analgesic regimen, 
Pregabalin (PGB) has been proposed as an adjunct in 
multimodal postoperative analgesia management (9). 
PGB inhibits the neurotransmitter gamma-
aminobutyric acid (GABA) (10). The tissue damage 
causes increased excitability of dorsal root neurons 
which is reduced with gabapentinoids (11). The α2δ1 
subunit of calcium channels which are voltage-gated is 
bound by PGB and Gabapentin, which is a predecessor 
of PGB (10). It is expeditiously and extensively 
absorbed following oral intake, with maximum plasma 
concentration at one hour following solitary or 
multiple doses. The oral bioavailability is 90% and is 
not related to the dosage. 
Most anesthesiologists and surgeons lately, rely 
on multimodal analgesia to manage postoperative pain 
effectively. Various research studies have been 
conducted in the past to explore the effectiveness of 
high-dose PGB in LC. Even though there have been 
positive outcomes, studies were hindered due to the 
high incidence of adverse effects like headache, 
dizziness, and sedation to name a few. There are very 
few studies available to prove the efficacy of low-dose 
PGB for attenuation of pain following LC. Henceforth, 
we conducted a research study to analyze the effective 
dose of PGB to which patients are more amenable. 
 
 
Methods 
After obtaining approval from Ethical Committee, 
Kasturba Medical College, Mangaluru (Coded IEC 
KMC MLR 10-17/211, October 17, 2017), and written 
informed consent from the patients, the prospective 
randomized clinical study was carried out on 70 
patients admitted to a tertiary health care center to 
undergo laparoscopic cholecystectomy from 
September 2017 to June 2019, based on the 
CONSORT patient flow chart (Figure 1). 
The sample size was selected with 95% 
confidence level and 90% power regarding P75 
duration of the surgery, with the mean difference with 
the relative risk of 10%, sample size comes to be 35 per 
group i.e. 70. 
 
ŋ= (Zα)2σ2 
d2 
Zα= 1.96 at 95% confidence interval,  
σ= combined SD,  
d= mean difference with the relative risk of 10% 
At the end of the study, all data were compiled 
systematically and analyzed using mean, the standard 
deviation was estimated, cross-tabulations were done. 
The categorical variable was analyzed using the Chi-
square test and the Continuous variable was calculated 
using the Student t-test using SPSS 17.0 (SPSS Inc. 
233 South Wacker Drive, 11th Floor, Chicago, IL 
60606-6412) for windows. Value of P<0.05 is 
considered significant and P<0.0001 is highly 
significant.  
70 cases are randomized into two equal groups 
A and B of 35 each who fulfill the inclusion-exclusion 
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criteria was done using a sealed envelope system. The 
inclusion criteria included: ASA physical status (PS) 
grade I and II, 18-60 years of age, patients of either sex 
and patients scheduled to undergo elective LC. 
However, exclusion criteria included patients 
belonging to ASA PS grade III and above, patients with 
hepatic or renal derangements, patients on anti-
epileptic treatment, patients already on chronic NSAID 
medication, patients who refuse the study, or have 
known allergy and pregnant and pediatric patients. 
Thorough pre-anesthetic evaluation, baseline 
vitals of pulse, blood pressure, respiratory rate, body 
mass index, and the result of routine investigations 
were noted. The planned anesthetic and induction 
techniques were detailed to the patient. Nil per oral 
orders was advised as per standard guidelines, after 
taking written and informed consent. Pre-medication 
with 150 mg oral ranitidine was given a night before 
surgery. In group A, 75 mg oral PGB was given 1 hour 
before surgery. In group B, 150 mg oral PGB was 
given 1 hour before surgery, respectively. Static and 
dynamic pain was evaluated at 0, 0-4, 4-8, 8-12, 12-16, 
16-24 hours after surgery using VAS Score. Patients 
with pain corresponding to a score equal to or greater 
than 4mm at rest were provided rescue analgesia with 
injecting. Paracetamol (PCT) 1g over 15 to 20 minutes 
intravenously, followed by TID dose. The episode of 
PONV at 0-6 hours was treated with an injection, using 
4 mg IV Ondansetron as rescue antiemetic. Headache, 
respiratory depression, and sedation as per Ramsay's 
sedation score were assessed for 0-24 hours. 
 
 
Results 
The mean age, sex, ASA status, and body mass index 
in Group A and B were comparable. The mean duration 
of surgery in Group A was 102.1 minutes and Group B 
104.4 minutes. The p-value was 0.454, statistically not 
significant. The mean intraoperative intravenous 
fentanyl consumption in Group A was 127.86 mcg, 
which was comparable to Group B, 128.57 mcg, with 
a standard deviation of 34.18 and 23.59. The T-test p-
value was 0.919, which is statistically not significant. 
 
Figure 1. CONSORT Flow Chart depicting the study selection process. 
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The VAS scores at rest i.e., Static measured at 
the end of 0, 0-4, 4-8, 8-12, 12-16, 16-24 hours, the 
highest mean score of 3.09 and 3.06 were at 0-4 hours 
before the administration of analgesic. The p-value was 
0.703, comparable, between the groups and 
statistically not significant. The trend of VAS score 
between the two groups was comparable at respective 
time intervals. 
The VAS scores on coughing i.e., Dynamic 
measured at the end of 0, 0-4, 4-8, 8-12, 12-16, 16-24 
hours, the highest mean score of 4.06 and 3.91 were at 
0-4 hours before the administration of analgesic. The 
p-value was 0.424, comparable between the groups and 
statistically not significant. The trend of VAS score 
amongst the two groups was comparable at respective 
time intervals. Intravenous paracetamol consumption 
was congruent between the groups with the mean value 
of 3.37 and 3.2g. It was statistically not significant with 
a p-value of 0.679. 
The incidence of PONV at 0-6 hours was higher 
in Group B when compared to Group A with a mean of 
0.77 and 0.40. It was statistically significant 
(Mannwhitney’s test, P-value= 0.04; Figure 2).  
40% of Group B patients complained of a 
headache when compared to 17% in Group A. This was 
statistically significant (Chi-square test, P-value= 
 
Figure 2. Incidence of PONV in the patients. 
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Figure 3. Headache in the patients. 
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0.034, Figure 3).  
Ramsay sedation scores in the majority of the 
patients of both the groups were 2, i.e., cooperative, 
oriented with a mean of 82.86% in Group A and 
62.86% in Group B. 8.57% of patients in either group 
were anxious and restless with a score of 1. 22.86% 
patients in group B responded to commands only when 
compared to 8.57% in Group A (Ramsay score 3). 
Only 5.71% of patients in Group B and none in Group 
A had a quick response to light tap over the glabella or 
loud sound (Ramsay score 4). Mann-Whitney's test p-
value was 0.148, which was statistically not 
significant. Only 2.9% of patients (1 patient) in Group 
B had respiratory depression with no significance 
established with a p-value of 0.10. 
 
 
Discussion 
Laparoscopically executed surgeries have attained 
popularity in the recent few decades. According to 
numerous reports, LC offers remarkable advantages 
when compared to open cholecystectomy, and is the 
imminent standard operation for symptomatic 
gallstone disease. Studies have proved to show that 
there is a marked decrease in the span of 
hospitalization, the duration of recovery, and also the 
expenditure (12). 
The incision preceded by pre-emptive analgesia 
pivots the postoperative pain management including a 
reduction in the consumption of analgesics, along with 
potent neuroprotective characteristics (12, 13). The 
purpose of multimodal analgesia is to enhance the level 
of analgesia and even to decrease opioid-related 
adverse effects (14). PGB has been known to have 
antihyperalgesic effects and decrements in central and 
peripheral sensitization following tissue or nerve 
injury (15, 16). 
Our research study demonstrates the efficacy of 
two different pre-emptive doses of oral PGB 75mg 
(group A) and 150mg (group B) on the postoperative 
pain and analgesic requirement following elective LC 
under general anesthesia. It even elucidates the dose-
related adverse effects of PGB. In our study, the 
highest VAS score at rest (static) of 3.09 was seen in 
group A patients between 0-4 hours which was 
comparable to group B with a static VAS of 3.06 at 0-
4 hours. It was statistically not significant (p=0.703). 
Similarly, the VAS score on coughing (Dynamic) was 
highest at 0-4 hours in both the groups with scores of 
4.06 and 3.91, respectively. As the p-value was 0.424, 
it did not show significance.  
This accords with the research study conducted 
by Agarwal et al in 2008 where the single pre-emptive 
dose of 150 mg oral PGB reduced both static and 
dynamic pain post LC when compared with placebo, 
with the highest VAS score recorded at 0-4 hours. It 
was statistically significant (13). Peng et al performed 
a research study to analyze the effects of low-dose 
PGB in patients undergoing LC. When compared to the 
placebo and PGB 50mg groups, static and dynamic 
pain scores after surgery were lesser in the first 45 
minutes and 90 minutes respectively, with PGB 75mg 
group (12). In contrast, Jokela et al found that static 
dynamic VAS scores for pain were lesser in the initial 
recovery following premedication with PGB 150mg 
when compared to PGB 75mg or diazepam 5mg, all 
combined with ibuprofen 800mg after gynecological 
laparoscopic surgery. VAS scale far pain was lesser in 
PGB 150 mg and statistically significant (14). 
The mean total intravenous paracetamol 
consumption in Group A was 2.02g with a standard 
deviation of 0.8 when compared to 1.9g in Group B 
with a standard deviation of 0.72. It was statistically 
not significant (p=0.79). Agarwal et al demonstrated 
the decremented patient-controlled consumption of 
fentanyl with oral PGB 150mg in comparison with the 
placebo group which showed statistical significance 
(p<0.05) (13). 
Even in the systematic review designed by 
Zhang et al to evaluate the efficacy of PGB in acute 
post-surgical pain, they found a significant reduction in 
opioid usage due to PGB administration in the first 
24hours following surgery (17). In contrast, Hu et al 
who steered a research study to analyze the efficiency 
of one single dose of pre-emptive PGB and gabapentin 
in acute post-surgical analgesia management, found 
that there was a consistent decrease in 24- hour opioid 
consumption with an augmented dose of PGB and 
gabapentin. A higher dose (>150mg) of PGB was 
strikingly efficient in reducing pain score compared to 
75mg for a 24-hour static pain score.  
The occurrence of PONV was significant in 
Group B with a P-value of 0.04 (18). Likewise, 
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Agarwal et al found that the occurrence and grade of 
PONV and even the size of patients requiring anti-
emetics were comparable among PGB 150mg and 
placebo group, p-value > 0.05 (13). Furthermore, Hu J 
et al had similar findings in their studies where the 
overall occurrence of PONV was decremented in the 
PGB group contrary to the control group and 
Gabapentin group. Nevertheless, PGB 150 mg had a 
higher incidence of PONV when compared to PGB 
75mg, but it was statistically not significant (18).  
The occurrence of headache was remarkably 
high in group B in contrast to Group A, with a p-value 
of 0.034. Similarly, Chang S.H et al found that the 
incidence of headache was more in PGB 150 mg 
compared to the placebo group (15). Whereas Jokela R 
et al found the incidence of a headache to be higher in 
PGB 75mg when compared to PGB 150mg but it was 
statistically not significant (14). 
The incidence of respiratory depression, 
sedation was comparable between both groups A and 
B. Peng P.W.H, et al also found that occurrences of 
blurred vision and sedative effect were more in the 
PGB group 50mg as well as 75mg compared to the 
placebo group (12). 
It was a single-blind study; Therefore, observer 
bias may play a vital role in assessing the clinical 
assays. There was considerable dependence on the 
patient to assess various clinical parameters, which 
might add to bias. 
 
 
Conclusion 
Pre-emptive doses of PGB 75 mg and 150 mg did not 
have any significant difference in VAS score for 
attenuation of pain post LC. PGB 75mg had lesser side 
effects of PONV and headache. Therefore, from our 
results, we can conclude that a lower dose of PGB has 
lesser adverse effects, although the analgesic effects 
are comparable. 
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